1) 13 June presentation shows $4.7m free cash flow, $5.75m EBITDA and $2-2.5m NPAT forecast for 2018. Debt post acquisitions is $8.1m so well under 2x EBITDA. I don't see why they won't achieve those figures since I suspect integration risks are low in this business.
2) The options have an exercise price of 5c - I will be more than happy to be diluted by them.
STL Price at posting:
2.3¢ Sentiment: Buy Disclosure: Held